495 related articles for article (PubMed ID: 19464595)
1. Tumor angiogenesis in melanoma.
Marneros AG
Hematol Oncol Clin North Am; 2009 Jun; 23(3):431-46, vii-viii. PubMed ID: 19464595
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor receptors: expression and function in solid tumors.
Wey JS; Stoeltzing O; Ellis LM
Clin Adv Hematol Oncol; 2004 Jan; 2(1):37-45. PubMed ID: 16163158
[TBL] [Abstract][Full Text] [Related]
3. Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction.
Wachsberger P; Burd R; Dicker AP
Clin Cancer Res; 2003 Jun; 9(6):1957-71. PubMed ID: 12796357
[TBL] [Abstract][Full Text] [Related]
4. Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas.
Jansen M; de Witt Hamer PC; Witmer AN; Troost D; van Noorden CJ
Brain Res Brain Res Rev; 2004 Jul; 45(3):143-63. PubMed ID: 15210301
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis, lymphangiogenesis, and melanoma metastasis.
Streit M; Detmar M
Oncogene; 2003 May; 22(20):3172-9. PubMed ID: 12789293
[TBL] [Abstract][Full Text] [Related]
6. Current concerns and challenges regarding tailored anti-angiogenic therapy in cancer.
Roukos DH; Tzakos A; Zografos G
Expert Rev Anticancer Ther; 2009 Oct; 9(10):1413-6. PubMed ID: 19828000
[No Abstract] [Full Text] [Related]
7. Potentiated antitumor effects of interleukin 12 and matrix metalloproteinase inhibitor batimastat against B16F10 melanoma in mice.
Dabrowska A; Giermasz A; Marczak M; Gołab J; Jakóbisiak M
Anticancer Res; 2000; 20(1A):391-4. PubMed ID: 10769685
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic targets of multiple angiogenic factors for the treatment of cancer and metastasis.
Cao Y; Liu Q
Adv Cancer Res; 2007; 97():203-24. PubMed ID: 17419947
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis in cutaneous malignant melanoma and potential therapeutic strategies.
Basu B; Biswas S; Wrigley J; Sirohi B; Corrie P
Expert Rev Anticancer Ther; 2009 Nov; 9(11):1583-98. PubMed ID: 19895243
[TBL] [Abstract][Full Text] [Related]
10. Beta-elemene inhibits melanoma growth and metastasis via suppressing vascular endothelial growth factor-mediated angiogenesis.
Chen W; Lu Y; Wu J; Gao M; Wang A; Xu B
Cancer Chemother Pharmacol; 2011 Apr; 67(4):799-808. PubMed ID: 20563582
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms and therapeutic development of angiogenesis inhibitors.
Cao Y
Adv Cancer Res; 2008; 100():113-31. PubMed ID: 18620094
[TBL] [Abstract][Full Text] [Related]
12. The combination of antiangiogenic therapy with other modalities.
O'Reilly MS
Cancer J; 2002; 8 Suppl 1():S89-99. PubMed ID: 12075706
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis. A boost for tumor starvation.
Marx J
Science; 2003 Jul; 301(5632):452-4. PubMed ID: 12881543
[No Abstract] [Full Text] [Related]
14. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.
Kerbel RS
Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079
[TBL] [Abstract][Full Text] [Related]
15. Molecular targets in melanoma from angiogenesis to apoptosis.
Sosman JA; Puzanov I
Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2376s-2383s. PubMed ID: 16609062
[TBL] [Abstract][Full Text] [Related]
16. Combining radiotherapy and angiogenesis inhibitors: clinical trial design.
Citrin D; Ménard C; Camphausen K
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):15-25. PubMed ID: 16377411
[TBL] [Abstract][Full Text] [Related]
17. Individualized therapy of disseminated cancer using malignant melanoma as a model.
Hauschild A; Egberts F; Russo P; Kähler KC
Cancer Metastasis Rev; 2006 Jun; 25(2):253-6. PubMed ID: 16770537
[TBL] [Abstract][Full Text] [Related]
18. New agents in the treatment of acute myeloid leukemia: a snapshot of signal transduction modulation.
Bao T; Smith BD; Karp JE
Clin Adv Hematol Oncol; 2005 Apr; 3(4):287-96, 302. PubMed ID: 16167001
[TBL] [Abstract][Full Text] [Related]
19. Ligustrazine inhibits B16F10 melanoma metastasis and suppresses angiogenesis induced by Vascular Endothelial Growth Factor.
Chen L; Lu Y; Wu JM; Xu B; Zhang LJ; Gao M; Zheng SZ; Wang AY; Zhang CB; Zhang WW; Lei N
Biochem Biophys Res Commun; 2009 Aug; 386(2):374-9. PubMed ID: 19523924
[TBL] [Abstract][Full Text] [Related]
20. Anti-angiogenic therapies in cancer: achievements and open questions.
Ruegg C; Mutter N
Bull Cancer; 2007 Sep; 94(9):753-62. PubMed ID: 17878094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]